"HCV Next" offers information on a range of topics which include new HCV combination therapies, side effects, drug/drug interaction, guidelines, practice management issues, to name a few.
The following articles appeared in the March print edition of HCV NEXT, provided online at Healio.
Cover Story
Narrowing the Gap: Cause for Optimism for Racial Minorities with HCV in the US
Editorial
Medicare Physician Payment: Prepare to ‘MACRA-Mize’ Your Practice
In the Journals
Few Infants Born to Mothers with HCV in Philadelphia Undergo Testing
Simeprevir/Sofosbuvir Yield High SVR Post-Liver Transplant
Faldaprevir Yields High SVR in Relapsers with HCV Genotype 1
Special Series
Global View Series: Sub-Saharan Africa
The Big Picture
Impact of Sustained Virologic Response in Hepatitis C Therapy
Stevan A. Gonzalez, MD, MS
Trend Watch
FDA Grants Priority Review of Supplemental NDA for Viekira Pak
FDA Approves Expanded Label of Daclatasvir for Additional HCV Patients
Sofosbuvir/Velpastasvir Receives Priority Review for All HCV Genotypes
No comments:
Post a Comment